1. Home
  2. MAN vs VCEL Comparison

MAN vs VCEL Comparison

Compare MAN & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ManpowerGroup

MAN

ManpowerGroup

HOLD

Current Price

$33.72

Market Cap

1.4B

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$44.54

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAN
VCEL
Founded
1948
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
MAN
VCEL
Price
$33.72
$44.54
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$35.67
$57.75
AVG Volume (30 Days)
1.1M
724.5K
Earning Date
04-16-2026
05-07-2026
Dividend Yield
4.69%
N/A
EPS Growth
N/A
60.00
EPS
0.05
N/A
Revenue
$17,957,100,000.00
$276,259,000.00
Revenue This Year
$5.12
$19.40
Revenue Next Year
$3.42
$18.24
P/E Ratio
$675.40
N/A
Revenue Growth
0.58
16.45
52 Week Low
$25.15
$28.95
52 Week High
$47.34
$46.62

Technical Indicators

Market Signals
Indicator
MAN
VCEL
Relative Strength Index (RSI) 53.65 73.47
Support Level $28.29 $32.47
Resistance Level $36.87 N/A
Average True Range (ATR) 1.64 1.73
MACD 0.04 0.68
Stochastic Oscillator 38.49 80.63

Price Performance

Historical Comparison
MAN
VCEL

About MAN ManpowerGroup

ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: